Risk factors

Janux Therapeutics (JANX) risk factors

Item 1A of every Janux Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open JANX in Gloom →
Janux Therapeutics' chart, financials and news, free in your browser.Open JANX in Gloom →
  • FY2025 10-K risk factors
    93 risks10 new7 dropped14 reworded

    Janux holds $966.6 million in cash as of December 31, 2025, down from $1.0 billion previously.

    Filed Feb 26, 2026
  • FY2024 10-K risk factors
    90 risks

    Janux is an early-stage biopharmaceutical company with no product revenue, relying entirely on external funding and unproven platform technologies like JANX007 and JANX008.

    Filed Feb 27, 2025